SPASMOLYTICS FOR IRRITABLE BOWEL SYNDROME IN THE CONTEXT OF EVIDENCE-BASED MEDICINE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper presents current ideas on irritable bowel syndrome, the bases of its pathophysiology, diagnostic criteria, and main directions in pharmacotherapy. Emphasis is laid on the value of spasmolytic agents, among which pinaverium bromide has a niche.

全文:

受限制的访问

作者简介

S. Cheremushkin

Moscow State University of Medicine and Dentistry

Email: svch555362@yandex.ru
Candidate of Medical Sciences

I. Mayev

Moscow State University of Medicine and Dentistry

Professor, MD

Yu. Kucheryavyi

Moscow State University of Medicine and Dentistry

Candidate of Medical Sciences

N. Cheremushkina

Moscow State University of Medicine and Dentistry

Candidate of Medical Sciences

参考

  1. Agreus I., Svardsudd K., Nyreu O. et al. Irritable bowel syndrome and dyspepsia in the population: overlap and lack of stability over time // Gastroenterology. - 1995; 109: 671-680.
  2. Barbara G., Stanghellini V., DeGiorgio R. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome // Gastroenterology. - 2004: 126: 693-702.
  3. Brandt L., Chey W., Foxx-Orenstein A. et al. An evidence-based position statement on the management of irritable bowel syndrome // Am. J. Gastroenterol. -2009; 104 (1): 1-35.
  4. Burden S. Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice // J. Hum. Nutr. Diet. - 2001: 14: 231-241.
  5. Chey W., Jin H., Lee M. et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibition abdominal pain and diarrhea // Am. J. Gastroenterol. - 2001; 96 (5): 1499-1506.
  6. Clemens C., Samsom M., Roelofs J. et al. Association between pain episodes and high amplitude propagated pressure waves in patients with irritable bowel syndrome // Am. J. Gastroenterol. - 2003; 98 (8): 1838-1843.
  7. Drossman D., Camileri M., Mayer E. et al. AGA technical review on irritable bowel syndrome // Gastroenterology. - 2002; 123 (6): 2108-2131.
  8. Drossman D. The Functional Gastrointestinal Disorders and the Rome III Process // Gastroenterology. - 2006; 130 (5): 1377-1390.
  9. Drossman D., Morris C., Hu Y. et al. A prospective assessment of bowel habit in irritable bowel syndrome: defining an alternator // Gastroenterology. -2005; 128: 580-589.
  10. Fukudo S., Kanazava M., Kano M. et al. Exagerrated motility of the descending colon with repetitive distention of the sigmoid colon in patient with irritable bowel syndrome // J. Gastroenterol. - 2002; 37 (14): 145-150.
  11. Glasgow R., Mulvihil S. Abdominal pain, including the acute abdomen. Sleisenger&Fordtrans’s Gastroentestinal and Liver Disease. - Philadelphia; London; Toronto; Monreal; Sydney; Tokyo, 2003. - Vol. 1. - P. 80-90.
  12. Guilera M., Balboa A., Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review // Am. J. Gastroenterol. -2005; 100: 1174-1184.
  13. Heaton K., O’Donnell L., Braddon F. et al. Symptoms of irritable bowel syndrome in a British urbancommunity: consulters and nonconsalters // Gastroenterology. -1992; 102: 1962-1967.
  14. Holzer P. Tachykinin Receptor Antagonists: Silencing Neuropeptides with a Role in the Disturbed Gut. / A Basis for Understanding Functional Diseases. Edited by R. Spiller and D. Grundy Blackwell Publishing, 2004.
  15. Hyams J., Burke G., Davis P. et al. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study // J. Pediatr. - 1996; 129 (2): 220-226.
  16. Irritable colon syndrome treated with an antispasmodic drug // Practitioner. -1976; 217 (1298): 276-280.
  17. Longstreth G., Thompson W., Chey W. et al. Functional Bowel Disorders. The Functional Gastrointestinal Disorders and the Rome III Process // Gastroenterology. - 2006; 130 (5): 1377-1390.
  18. Mearin F., Balboa A., Badia X. et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype // Eur. J. Gastroenterol. Hepatol. - 2003; 15: 165-172.
  19. O'Donnell L., Virjee J., Heaton K. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate // Br. Med. J. - 1990; 300: 439-440.
  20. Page J., Dirnberger G. Treatment of the irritable bowel syndrome with Bentyl (dicyclomin hydrochlorid) // J. Clin. Gastroenterol. - 1981; 3 (2): 153-156.
  21. Ragnarsson G., Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study // Eur. J. Gastroenterol. Hepatol. - 1998; 10 (5): 415-421.
  22. Ragnarsson G., Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples // Scand. J. Gastroenterol. - 1999; 34: 993-10-00.
  23. Ruepert T., Quartero А., de Wit N. et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome (Review) // The Cochrane Library; 2011, Issue 8.
  24. Talley N., Weaver A., Zinsmeister A. et al. Onset and disappearence of gastrointestinal symptoms and functional gastrointestinal disorders // Am. J. Epidimiol. - 1992; 136: 165-177.
  25. Talley N. Pharmacologic therapy for the irritable bowel syndrome // Am. J. Gastroenterol. - 2003; 98 (4): 750-758.
  26. Taub E., Cuevas J., Cook E. et al. Irritable bowel syndrome defined by factor analysis, gender and race comparisons // Dig. Dis. Sci. - 1995; 40: 2647-2655.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##